Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/6/2026

Management of Behavioral Variant Frontotemporal Dementia

Diagnostic Considerations

  • Brain MRI with T1 and FLAIR sequences is essential for diagnosis, with FDG-PET recommended in ambiguous cases to detect frontal or anterior temporal atrophy that increases diagnostic certainty from "possible" to "probable" bvFTD 1, 2
  • Social cognition testing is critical for diagnosis, as deficits in this domain are more severe in bvFTD than in psychiatric disorders 3, 4
  • Genetic testing for C9orf72 mutation should be strongly considered in all possible/probable bvFTD cases, especially those with prominent psychiatric features 1
  • Obtain detailed history with caregiver input, as impaired insight is almost always present in bvFTD patients 1

Assessment of Social Cognition Deficits

  • Evaluate emotion recognition using standardized tests such as the Ekman 60 Faces Test, which has been shown to discriminate between bvFTD and psychiatric disorders 4, 5
  • Assess Theory of Mind (ToM) deficits using tests like The Awareness of Social Inference Test (TASIT), as both cognitive and affective components of ToM are affected in bvFTD 6, 7
  • Measure empathic deficits using the Interpersonal Reactivity Inventory (IRI), as both cognitive and affective components of empathy are typically affected 5, 8
  • Evaluate moral reasoning using verbal or pictorial scenarios describing moral situations followed by judgment queries 5

Non-Pharmacological Interventions

  • Implement structured routines to compensate for executive dysfunction and social cognition deficits 1
  • Provide environmental adaptations to support daily functioning and accommodate the fluctuating nature of symptoms 1
  • Utilize speech and language therapy focused on regaining voluntary control over speech and addressing communication difficulties 1
  • Employ occupational therapy interventions that include education about bvFTD as a real, disabling condition with symptoms outside the person's control 1
  • Teach self-management strategies, including redirecting attention and implementing rehabilitation strategies throughout daily routines 1

Caregiver Support and Education

  • Provide education to caregivers about bvFTD symptoms, particularly the loss of social judgment and empathy 1
  • Implement caregiver support programs to address the significant burden associated with caring for individuals with bvFTD 1

Common Pitfalls and Caveats

  • Be aware that some patients may present with non-progressive "phenocopy" frontotemporal dementia, which requires different management approaches 1
  • Recognize that bvFTD symptoms often follow a pattern of remission and exacerbation, requiring flexible approaches to goal-setting 1
  • Avoid overuse of adaptive equipment in early phases, as this may reinforce maladaptive patterns 1
  • Remember that executive dysfunction is not always the most prominent deficit in bvFTD and may not even be present on formal neuropsychological test results in early stages 7
  • Consider that 10% of pathologically-confirmed bvFTD subjects show marked episodic memory deficits at initial presentation, contrary to current diagnostic criteria 3

Assessment and Management of Theory of Mind Deficits in Psychiatric and Neurodegenerative Disorders

Assessment Tools

  • Structured social‑cognition testing (e.g., Ekman 60 Faces, TASIT) should be performed to differentiate neurodegenerative from psychiatric conditions, capturing both cognitive and affective Theory of Mind components. 9, 10
  • The Ekman 60 Faces Test reliably distinguishes behavioral‑variant frontotemporal dementia (bvFTD) from psychiatric disorders based on emotion‑recognition performance. 10, 11
  • The Awareness of Social Inference Test (TASIT), which uses dynamic video vignettes, assesses understanding of sarcasm and lies and reflects real‑world social‑inference abilities missed by static tests. 10
  • The Reading the Mind in the Eyes Test (RMET) evaluates both cognitive and affective Theory of Mind and aids in differentiating bipolar disorder from neurodegenerative conditions. 10
  • An informant‑based clinical interview that asks about the patient’s behavior in social situations, difficulty understanding others’ feelings, and changes in empathy is essential for screening social‑cognition deficits. 11

Differential Diagnosis Considerations

  • Social‑cognition impairment is markedly more severe in bvFTD than in major psychiatric disorders, autism spectrum disorder, or ADHD. 10
  • Patients with schizophrenia show persistent deficits in sarcasm and lie detection regardless of contextual information, whereas bvFTD patients improve when additional context is provided. 10

Pharmacological Management

  • Selective serotonin reuptake inhibitors are recommended for comorbid anxiety and depression that exacerbate social dysfunction. 12
  • Short‑acting anxiolytics (e.g., alprazolam) may be used for acute anxiety interfering with social functioning, but psychotherapy remains the primary intervention. 12
  • Medication alone is insufficient for Theory of Mind deficits; behavioral and cognitive interventions are required. 12

Clinical Caveats

  • Global cognitive‑screening test scores should not be solely relied upon to distinguish psychiatric from neurodegenerative causes of Theory of Mind deficits, as early executive dysfunction may be absent. 11
  • Approximately 10 % of pathologically confirmed bvFTD cases initially present with prominent episodic‑memory deficits rather than social‑cognition problems. 9